Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,115 | 310 | 97.5% |
| Education | $205.94 | 3 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,400 | 40 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,222 | 33 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $975.01 | 30 | $0 (2024) |
| Novo Nordisk Inc | $736.21 | 35 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $607.89 | 26 | $0 (2024) |
| Lilly USA, LLC | $578.61 | 27 | $0 (2024) |
| ABBVIE INC. | $374.82 | 5 | $0 (2022) |
| Astellas Pharma US Inc | $355.64 | 14 | $0 (2023) |
| PFIZER INC. | $340.29 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $302.84 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $902.87 | 23 | AstraZeneca Pharmaceuticals LP ($389.89) |
| 2023 | $1,205 | 43 | Janssen Pharmaceuticals, Inc ($498.74) |
| 2022 | $1,034 | 39 | ABBVIE INC. ($268.58) |
| 2021 | $552.45 | 34 | Janssen Pharmaceuticals, Inc ($79.79) |
| 2020 | $657.32 | 33 | AstraZeneca Pharmaceuticals LP ($178.85) |
| 2019 | $1,320 | 39 | SANOFI-AVENTIS U.S. LLC ($245.23) |
| 2018 | $1,105 | 45 | SANOFI-AVENTIS U.S. LLC ($482.71) |
| 2017 | $1,545 | 57 | SANOFI-AVENTIS U.S. LLC ($278.05) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $131.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Oncology | ||||||
| 04/30/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: VACCINES | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: HEMATOLOGY | ||||||
| 03/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.56 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Cardio-renal | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: Cardiology | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 01/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 523 | 991 | $119,294 | $51,303 |
| 2022 | 11 | 667 | 1,330 | $159,863 | $66,934 |
| 2021 | 13 | 723 | 1,424 | $161,279 | $80,047 |
| 2020 | 11 | 631 | 1,335 | $114,170 | $52,823 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 335 | $50,555 | $20,464 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 193 | $39,320 | $18,198 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $10,090 | $5,219 | 51.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $7,230 | $3,990 | 55.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 116 | 202 | $4,054 | $1,697 | 41.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 36 | 36 | $2,200 | $686.88 | 31.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 53 | 120 | $3,600 | $385.20 | 10.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $360.00 | $352.80 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 29 | $1,885 | $310.25 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 530 | $79,350 | $32,851 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 239 | $47,550 | $20,906 | 44.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $10,000 | $5,312 | 53.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 23 | 23 | $6,900 | $3,980 | 57.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $860.00 | $832.88 | 96.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 41 | 41 | $2,460 | $785.89 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 135 | 211 | $4,220 | $626.31 | 14.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 69 | 158 | $4,740 | $512.88 | 10.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $450.00 | $441.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 34 | 37 | $2,405 | $438.92 | 18.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 23 | $928.40 | $248.17 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 199 | 536 | $74,200 | $35,903 | 48.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 339 | $63,071 | $34,146 | 54.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $4,166 | $3,008 | 72.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,650 | $1,588 | 59.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 19 | 20 | $1,450 | $1,284 | 88.5% |
About Dr. Gilbert Leung, M.D
Dr. Gilbert Leung, M.D is a Internal Medicine healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1528117314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Leung, M.D has received a total of $8,321 in payments from pharmaceutical and medical device companies, with $902.87 received in 2024. These payments were reported across 313 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,115).
As a Medicare-enrolled provider, Leung has provided services to 2,544 Medicare beneficiaries, totaling 5,080 services with total Medicare billing of $251,108. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location North Miami, FL
- Active Since 01/09/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528117314
Products in Payments
- XARELTO (Drug) $1,313
- JARDIANCE (Drug) $631.96
- FARXIGA (Drug) $565.18
- SOLIQUA (Drug) $539.33
- Tresiba (Drug) $322.57
- TOUJEO (Drug) $309.72
- UBRELVY (Drug) $284.98
- TRULICITY (Drug) $256.82
- AIRSUPRA (Drug) $236.49
- SOLIQUA 100/33 (Biological) $182.75
- SOLIQUA 100/33 (Drug) $156.94
- ELIQUIS (Drug) $155.97
- Ozempic (Drug) $154.84
- Repatha (Biological) $146.69
- Vemlidy (Drug) $145.73
- MOUNJARO (Drug) $125.99
- BYDUREON (Drug) $125.00
- ENTRESTO (Drug) $124.93
- TRELEGY ELLIPTA (Drug) $119.51
- INVOKANA (Drug) $86.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Miami
Mr. Manuel Suarez Barcelo, Md, MD
Internal Medicine — Payments: $240,589
Sheren Leung, D.o, D.O
Internal Medicine — Payments: $12,126
Dr. Nasiruddin Nazarally, M.d, M.D
Internal Medicine — Payments: $6,825
Dr. Luis Perez, D.o, D.O
Internal Medicine — Payments: $5,990
Eliades Carmenate, M.d, M.D
Internal Medicine — Payments: $5,003
Hamidreza Moghaddam, M.d, M.D
Internal Medicine — Payments: $4,735